DEUTSCHE BANK AG\
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 948046
FRANKFURT AM MAIN, 2M
Position in VRTX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$686,660,626
-$115,279,259 QoQ
Shares Held
1,537,736
-13.1% QoQ
Ownership
0.606%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 37.129715373770274.ToString("F0")%
Shared 0.ToString("F0")%
None 62.87028462622973.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,467,737 across 247 Biotechnology names. VRTX ranks #1 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $686,660,626 | 1,537,736 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $801,939,885 | 1,768,881 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $626,802,579 | 1,600,456 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $626,678,650 | 1,407,634 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $652,997,264 | 1,346,886 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $559,593,928 | 1,389,605 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $610,608,176 | 1,312,910 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $646,514,866 | 1,379,320 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $659,143,661 | 1,576,861 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $670,011,516 | 1,646,665 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $461,231,202 | 1,326,368 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $561,859,497 | 1,596,600 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $553,313,324 | 1,756,160 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $535,133,011 | 1,853,082 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $529,121,889 | 1,827,457 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $575,181,850 | 2,041,172 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $560,726,919 | 2,148,626 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $562,025,130 | 2,559,313 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $487,320,736 | 2,686,591 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $551,238,268 | 2,733,910 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $438,169,085 | 2,039,039 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $296,800,730 | 1,255,821 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $277,501,168 | 1,019,775 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $262,170,825 | 903,072 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $223,509,046 | 939,311 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||